Drug-eluting coronary stents are being used with increasing frequency in patients undergoing percutaneous coronary intervention. Although these stents have shown remarkably low rates of restenosis compared with their predecessors, there have been increasing concerns lately regarding their safety. Extensive data have been published that demonstrate a higher risk of very late stent thrombosis with drug-eluting stents; however, this has not had any impact on long-term mortality or the risk of myocardial infarction when compared with bare-metal stents. Their overall net clinical benefit therefore still favors their use. Recent research has led to a greater understanding of the multifactorial cause of stent thrombosis, which has enabled measures to be taken to reduce an individual patients risk. In the future, new stent designs and new antiplatelet agents may help to reduce this risk further.

Coronary artery disease, Drug-eluting stents, Mortality, Safety, Stent thrombosis
dx.doi.org/10.1586/erc.09.138, hdl.handle.net/1765/32763
Expert Review of Cardiovascular Therapy
Erasmus MC: University Medical Center Rotterdam

Garg, S.A, & Serruys, P.W.J.C. (2010). Benefits of and safety concerns associated with drug-eluting coronary stents. Expert Review of Cardiovascular Therapy (Vol. 8, pp. 449–470). doi:10.1586/erc.09.138